Pulmonx Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Pulmonx Corporation (LUNG) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-56.39-60.84-58.92-48.66-32.23
Depreciation & Amortization1.491.551.510.872.88
Stock Based Compensation22.9622.1016.4510.533.20
Change in Working Capital-1.70-2.56-7.01-7.85-3.91
Change in Accounts Receivable-1.31-3.10-2.19-2.431.46
Change in Inventory-0.230.92-3.64-6.46-5.05
Change in Accounts Payable2.24-0.350.120.090.59
Change in Other Working Capital1.90-0.102.550.85-1.55
Other Operating Activities1.903.192.553.552.63
Net Cash from Operating Activities-31.54-37.61-45.08-41.39-30.60
Investing Activities
Capital Expenditures-1.45-0.81-1.32-3.670.91
Purchases of Investments-27.91-1.20-47.19-42.5813.61
Sales/Maturities of Investments46.8445.0044.2810.0013.61
Net Cash from Investing Activities17.48-2.01-4.23-46.2612.69
Financing Activities
Debt Repayment-0.10-0.09-0.09-0.04-20.08
Common Stock Issued1.461.49-0.034.52201.39
Other Financing Activities0.000.00-0.05-0.07-1.88
Net Cash from Financing Activities1.3621.402.424.46234.83
Summary
Effect of Forex Changes on Cash0.080.030.150.110.13
Net Change in Cash-12.70-18.18-46.89-83.08217.03
Cash at Beginning of Period83.78101.97148.71231.7914.77
Cash at End of Period71.16-37.61101.97148.71231.79
Free Cash Flow-32.98-38.42-46.40-45.06-31.51
Supplemental Disclosures
Interest Paid3.482.980.850.723.06
Income Taxes Paid0.560.470.400.320.26